Steven J. Feigenberg

7.2k total citations · 3 hit papers
191 papers, 5.2k citations indexed

About

Steven J. Feigenberg is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, Steven J. Feigenberg has authored 191 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 125 papers in Pulmonary and Respiratory Medicine, 74 papers in Radiation and 59 papers in Oncology. Recurrent topics in Steven J. Feigenberg's work include Advanced Radiotherapy Techniques (73 papers), Lung Cancer Diagnosis and Treatment (51 papers) and Lung Cancer Treatments and Mutations (35 papers). Steven J. Feigenberg is often cited by papers focused on Advanced Radiotherapy Techniques (73 papers), Lung Cancer Diagnosis and Treatment (51 papers) and Lung Cancer Treatments and Mutations (35 papers). Steven J. Feigenberg collaborates with scholars based in United States, Netherlands and Canada. Steven J. Feigenberg's co-authors include Alan Pollack, Benjamin Movsas, Eric M. Horwitz, Alexandra L. Hanlon, Robert G. Uzzo, André Konski, Nancy P. Mendenhall, Walter J. Scott, John A. Howington and Katherine M.W. Pisters and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Steven J. Feigenberg

177 papers receiving 5.1k citations

Hit Papers

Multi-Institutional Phase I/II Trial of Stereotactic Body... 2009 2026 2014 2020 2009 2013 2025 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven J. Feigenberg United States 39 3.3k 1.8k 1.4k 1.3k 912 191 5.2k
Filippo Alongi Italy 39 4.3k 1.3× 3.6k 2.0× 1.1k 0.8× 2.3k 1.8× 1.0k 1.1× 320 6.7k
Éric Lartigau France 34 2.0k 0.6× 1.4k 0.8× 946 0.7× 1.3k 1.0× 905 1.0× 249 4.7k
Jun Itami Japan 32 3.1k 0.9× 2.1k 1.1× 1.1k 0.8× 1.8k 1.4× 1.2k 1.4× 258 5.9k
Mary Feng United States 36 2.2k 0.7× 1.9k 1.0× 896 0.6× 1.7k 1.3× 1.4k 1.5× 108 5.2k
Inga S. Grills United States 43 3.3k 1.0× 2.8k 1.5× 751 0.5× 2.0k 1.5× 888 1.0× 169 6.0k
Wim L.J. van Putten Netherlands 56 2.8k 0.9× 1.5k 0.8× 2.6k 1.9× 1.0k 0.8× 1.5k 1.7× 155 10.5k
Thomas A. DiPetrillo United States 41 2.5k 0.8× 1.3k 0.7× 1.3k 0.9× 876 0.7× 1.3k 1.5× 151 5.3k
Jean‐Marc Cosset France 34 2.3k 0.7× 1.2k 0.7× 762 0.5× 1.3k 1.0× 470 0.5× 126 4.2k
Rebecca Paulus United States 34 5.6k 1.7× 2.3k 1.2× 2.3k 1.6× 1.9k 1.4× 623 0.7× 95 7.0k
Gert De Meerleer Belgium 35 4.4k 1.3× 1.9k 1.0× 724 0.5× 1.8k 1.4× 839 0.9× 168 5.5k

Countries citing papers authored by Steven J. Feigenberg

Since Specialization
Citations

This map shows the geographic impact of Steven J. Feigenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Feigenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Feigenberg more than expected).

Fields of papers citing papers by Steven J. Feigenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Feigenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Feigenberg. The network helps show where Steven J. Feigenberg may publish in the future.

Co-authorship network of co-authors of Steven J. Feigenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Feigenberg. A scholar is included among the top collaborators of Steven J. Feigenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Feigenberg. Steven J. Feigenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yegya‐Raman, Nikhil, et al.. (2025). Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy. Radiotherapy and Oncology. 208. 110911–110911. 1 indexed citations
2.
Lee, Sang Ho, Bolin Li, William P. Levin, et al.. (2023). Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1435–1444. 9 indexed citations
3.
Lee, Sang Ho, Lova Sun, Roger B. Cohen, et al.. (2023). Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation. International Journal of Radiation Oncology*Biology*Physics. 117(2). S169–S170. 1 indexed citations
4.
Lee, Sang Ho, Bolin Li, Abigail Doucette, et al.. (2023). The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiotherapy and Oncology. 190. 110030–110030. 17 indexed citations
5.
Goia, Denisa, Khayrullo Shoniyozov, Swapnil V. Shewale, et al.. (2021). A Novel Mouse Model of Radiation-Induced Cardiac Injury Reveals Biological and Radiological Biomarkers of Cardiac Dysfunction with Potential Clinical Relevance. Clinical Cancer Research. 27(8). 2266–2276. 38 indexed citations
6.
Pietrofesa, Ralph A., Evguenia Arguiri, Constantinos Koumenis, et al.. (2021). Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer. The Journal of Alternative and Complementary Medicine. 27(10). 824–831. 6 indexed citations
7.
Frick, Melissa A., Steven J. Feigenberg, Samuel Swisher‐McClure, et al.. (2020). Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy. Clinical Cancer Research. 26(10). 2372–2380. 44 indexed citations
8.
Jain, Varsha, Chingyun Cheng, Boon‐Keng Teo, et al.. (2020). Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 107(1). 79–87. 27 indexed citations
9.
Sun, Lova, Christiana Davis, Wei‐Ting Hwang, et al.. (2020). Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy. Clinical Lung Cancer. 22(1). 58–66.e3. 30 indexed citations
10.
Rice, Stephanie R., Jason K. Molitoris, Melissa A.L. Vyfhuis, et al.. (2018). Lymph Node Size Predicts for Asymptomatic Brain Metastases in Patients With Non–small-cell Lung Cancer at Diagnosis. Clinical Lung Cancer. 20(1). e107–e114. 13 indexed citations
11.
Bluebond‐Langner, Rachel, Sally B. Cheston, E.M. Nichols, et al.. (2017). Effect of reduction mammoplasty on acute radiation side effects and use of lumpectomy cavity boosts. Practical Radiation Oncology. 7(5). e299–e308. 1 indexed citations
12.
Stinchcombe, Thomas E., David Kozono, Joseph K. Salama, et al.. (2017). MA 17.07 Veliparib in Combination with Paclitaxel/Carboplatin (P/C)-Based Chemoradiotherapy (CRT) in Patients with Stage III NSCLC. Journal of Thoracic Oncology. 12(11). S1874–S1874. 1 indexed citations
13.
Rice, Stephanie R., Jason K. Molitoris, Katherine H. R. Tkaczuk, et al.. (2017). Trends in Utilization of Hypofractionated Whole Breast Irradiation in Triple Negative Breast Cancer: A National Cancer Database Analysis. International Journal of Radiation Oncology*Biology*Physics. 99(2). E43–E44. 1 indexed citations
14.
Badiyan, Shahed N., Pranshu Mohindra, Gary Larson, et al.. (2017). Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated with Proton Therapy on the Proton Collaborative Group Prospective Registry Trial. International Journal of Radiation Oncology*Biology*Physics. 99(2). S209–S209. 1 indexed citations
15.
Snider, J.W., et al.. (2016). Preoperative Partial Breast Irradiation with a Novel Breast-Specific Stereotactic Radiotherapy (BSRT) Device: Projected Improvements in Cosmetic Outcomes over Volumetric Modulated Arc Therapy (VMAT). Cureus. 8(6). 1 indexed citations
16.
Pollack, Alan, Gail Walker, Eric M. Horwitz, et al.. (2013). Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer. Journal of Clinical Oncology. 31(31). 3860–3868. 340 indexed citations breakdown →
17.
Husain, Zain, Usama Mahmood, Alexandra L. Hanlon, et al.. (2011). Accelerated partial breast irradiation via brachytherapy: A patterns-of-care analysis with ASTRO consensus statement groupings. Brachytherapy. 10(6). 479–485. 29 indexed citations
18.
Cohen, R.J., Navesh Sharma, Jian Q. Yu, et al.. (2010). A phase I radiation dose escalation of stereotactic body radiotherapy for malignant lung tumors. Journal of Biomedical Science and Engineering. 3(4). 351–358. 2 indexed citations
19.
Kavanagh, Brian D., Tracey E. Schefter, Higinia R. Cárdenes, et al.. (2004). Biologically potent doses safely achieved in a multi-center trial of stereotactic body radiation therapy for liver metastases. International Journal of Radiation Oncology*Biology*Physics. 60(1). S412–S412. 1 indexed citations
20.
Monroe, Alan T., Steven J. Feigenberg, & Nancy P. Mendenhall. (2003). Angiosarcoma after breast‐conserving therapy. Cancer. 97(8). 1832–1840. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026